BUSINESS BRIEF
The company is a tech-enabled B2B pharma distribution platform revolutionizing medicine supply across India. It solves the inefficiencies of fragmented distribution through a one-roof digital solution offering real-time tracking, better margins for retailers, and reliable delivery of essential medicines.
Key Details:
- Supplier network includes over 75 multinational pharmaceutical companies, covering approximately 75% of the market
- Recent acquisitions completed to expand supplier base
- Plans to increase retail counters to over 4,000 by 2031
- Development of a proprietary B2B mobile application expected by March 2026
- Target EBITDA margin of 5% during growth
Products & Services
Pharmaceutical products
Proposal
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Services (Distributor)
Nature of Business
B2B
Sector
Distributor
Location
India
Region
Central
Open For Dilution
25 %
Top Customer
Ask
INR 15 Cr
End use of fund
Branding & Packaging, Team Expansion, Direct Sales Force, Marketing & Promotion and Technology Development
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
19.15 | 16.17 | 9.02 |
EBITDA |
|||
PAT |
